➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
Merck
McKinsey
McKesson
Boehringer Ingelheim
Baxter

Last Updated: August 1, 2021

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: GUANFACINE HYDROCHLORIDE


Email this page to a colleague

« Back to Dashboard

GUANFACINE HYDROCHLORIDE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Actavis Elizabeth GUANFACINE HYDROCHLORIDE guanfacine hydrochloride TABLET, EXTENDED RELEASE;ORAL 200881 ANDA Actavis Pharma, Inc. 0228-2850-11 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0228-2850-11) 2014-12-01
Actavis Elizabeth GUANFACINE HYDROCHLORIDE guanfacine hydrochloride TABLET, EXTENDED RELEASE;ORAL 200881 ANDA Actavis Pharma, Inc. 0228-2851-11 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0228-2851-11) 2014-12-01
Actavis Elizabeth GUANFACINE HYDROCHLORIDE guanfacine hydrochloride TABLET, EXTENDED RELEASE;ORAL 200881 ANDA Actavis Pharma, Inc. 0228-2853-11 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0228-2853-11) 2014-12-01
Actavis Elizabeth GUANFACINE HYDROCHLORIDE guanfacine hydrochloride TABLET, EXTENDED RELEASE;ORAL 200881 ANDA Actavis Pharma, Inc. 0228-2855-11 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0228-2855-11) 2014-12-01
Actavis Elizabeth GUANFACINE HYDROCHLORIDE guanfacine hydrochloride TABLET, EXTENDED RELEASE;ORAL 200881 ANDA AvKARE 42291-324-01 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (42291-324-01) 2015-07-09
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts
Johnson and Johnson
Harvard Business School
Dow
Mallinckrodt